The Effect of Education on Nurses' Knowledge About High-flow Nasal Cannula Oxygen Therapy

NCT ID: NCT05362279

Last Updated: 2022-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-10

Study Completion Date

2022-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to evaluate the oxygen therapy methods used in pediatric services and to specify the roles and responsibilities of nurses in the application of HFNC, which is one of these methods. Although the decision to implement this treatment method is under the responsibility of the physician in Turkey, the use of the device, observing the effectiveness of the treatment, monitoring and recording the changes in the vital signs of the children are under the responsibility of the nurses shows the importance of the nursing perspective on HFNC.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

High-flow nasal cannula oxygen therapy (HFNC) which meets the patient's ventilation need is a non-invasive ventilation system in which warmed and humidified oxygen is administered to the patient at varying flows with the help of a nasal cannula.This study will be conducted as a randomized controlled study with the participation of 70 nurses working in the pediatric clinics of a public hospital between December 2021 and May 2022, as an experimental group (n=35) and a control group (n=35). In the study, two-stage sampling method will be used to determine the nurses who will take place in the experimental and control groups. After the nurses are stratified according to their professional years, assignment to the experimental and control groups will be made by simple random sampling method. The experimental group will be given a pre-test before the training and a post-test one month after the training. In order to avoid interaction between the two groups, the data of the nurses in the control group will be collected first. The knowledge level of the nurses in the experimental and control groups will be evaluated with the HFNC Information Form.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled study with pretest-posttest experimental and control groups
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test after post-test training

Pre-test will be applied to the nurses in the experimental group before the training. The post-test will be applied to the experimental group, to which the pre-test was applied, one month after the training was given.

Group Type EXPERIMENTAL

Training

Intervention Type OTHER

One month after the pre-test, the post-test will be administered to the nurses who will be in the control group.

Nurses who will be in the experimental group will be given training after the pre-test. A post-test will be administered one month after the training.

Test without training

The nurses in the control group are the group to be administered the post-test without any intervention after the pre-test. The post-test will be administered one month after the pre-test.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training

One month after the pre-test, the post-test will be administered to the nurses who will be in the control group.

Nurses who will be in the experimental group will be given training after the pre-test. A post-test will be administered one month after the training.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Nurses working in any of the pediatric emergency departments, pediatric clinics
* No previous training in HFNC treatment
* Follow-up of patients treated with HFNC
* Volunteering to participate in research

Exclusion Criteria

* Those who have received in-service training on HFNC implementation
* Those who work as responsible nurses or training nurses in the clinics where the research will be conducted
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Izmir Katip Celebi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aslı Alaca

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aslı ALACA

Role: PRINCIPAL_INVESTIGATOR

Study Principal Investigator

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aslı Alaca

Role: CONTACT

+905052741676

References

Explore related publications, articles, or registry entries linked to this study.

Colleti Junior J, Longui TE, Carvalho WB. HIGH-FLOW NASAL CANNULA POST-TRACHEAL EXTUBATION IN A CHILD WITH UPPER AIRWAY OBSTRUCTION: CASE REPORT. Rev Paul Pediatr. 2018 Jul-Sep;36(3):372-375. doi: 10.1590/1984-0462/;2018;36;3;00010. Epub 2018 Jul 10.

Reference Type BACKGROUND
PMID: 29995143 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAlaca

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Child Abuse Training Impact on Nurses
NCT07050420 NOT_YET_RECRUITING NA